Showing results (71-80 of 154) with videos related to
Sort By:
Pageof 16
Pharmaceuticals (Basel, Switzerland)|July 8, 2020
Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 InfectionAndreia Palmeira, Emília Sousa, Aylin Köseler, et al.European Journal of Medicinal Chemistry|October 8, 2010
Efficient synthesis of 6-(hetero)arylthieno[3,2-b]pyridines by Suzuki-Miyaura coupling. Evaluation of growth inhibition on human tumor cell lines, SARs and effects on the cell cycleMaria-João R P Queiroz, Ricardo C Calhelha, Luís A Vale-Silva, et al.European Journal of Medicinal Chemistry|December 9, 2010
Synthesis and evaluation of tumor cell growth inhibition of methyl 3-amino-6-[(hetero)arylethynyl]thieno[3,2-b]pyridine-2-carboxylates. Structure-activity relationships, effects on the cell cycle and apoptosisMaria-João R P Queiroz, Ricardo C Calhelha, Luís A Vale-Silva, et al.Natural Product Communications|August 6, 2011
Sartoryglabrins, analogs of ardeemins, from Neosartorya glabraAnake Kijjoa, Sonia Santos, Tida Dethoup, et al.GE Portuguese Journal of Gastroenterology|September 5, 2017
Schwannoma-A Rare Subepithelial Lesion of the ColonSandra Barbeiro, Catarina Martins, Cláudia Gonçalves, et al.Journal of Medicinal Chemistry|August 2, 2024
Discovery of Potent Isoquinolinequinone N-Oxides to Overcome Cancer Multidrug ResistanceRyan D Kruschel, Mélanie A G Barbosa, Maria João Almeida, et al.Biosensors|April 3, 2021
Biosensors for Biogenic Amines: A ReviewHelena Vasconcelos, Luís C C Coelho, Ana Matias, et al.Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132Andreia Palmeira, Emília Sousa, Aylin Köseler, et al.Scandinavian Journal of Gastroenterology|October 3, 2022
Single-capsule bismuth-based quadruple therapy as a rescue therapy for Helicobacter pylori eradicationCatarina Correia, Nuno Almeida, Carina Leal, et al.International Journal of Pharmaceutics|July 17, 2013
Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interactionAna M Paiva, Rita A Pinto, Maribel Teixeira, et al.Pageof 16